APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Repurposing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Repurposing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchDrug Repurposing Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Repurposing Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Drug Repurposing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Repurposing Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Repurposing Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Repurposing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Repurposing include Novartis, Pfizer, AbbVie, NuMedii, Biovista, Astellas Pharma and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drug Repurposing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Repurposing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Repurposing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Repurposing market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Repurposing Segment by Company

Novartis

Pfizer

AbbVie

NuMedii

Biovista

Astellas Pharma

Allergan

Drug Repurposing Segment by Type

Neurodegenerative Diseases

CNS Diseases

Oncology

Others

Drug Repurposing Segment by Application

Hospitals

Ambulatory Surgical Centers

Others

Drug Repurposing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Repurposing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Repurposing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Repurposing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Repurposing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Repurposing industry.

Chapter 3: Detailed analysis of Drug Repurposing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Repurposingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Neurodegenerative Diseases Table 3. Key Players of CNS Diseases Table 4. Key Players of Oncology Table 3. Key Players of Others Table 4. Global Drug Repurposing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Ambulatory Surgical Centers Table 7. Key Players of Others Table 8. Global Drug Repurposing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Drug Repurposing Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Drug Repurposing Market Share by Region (2021-2026) Table 11. Global Drug Repurposing Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Drug Repurposing Market Share by Region (2027-2032) Table 13. Drug Repurposing Industry Trends Table 14. Drug Repurposing Industry Drivers Table 15. Drug Repurposing Industry Opportunities and Challenges Table 16. Drug Repurposing Industry Restraints Table 17. Global Drug Repurposing Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Drug Repurposing Revenue Market Share by Company (2021-2026) Table 19. Global Drug Repurposing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drug Repurposing Key Company Head Office and Area Served Table 21. Global Drug Repurposing Company, Product Type & Application Table 22. Global Drug Repurposing Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Drug Repurposing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Drug Repurposing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Drug Repurposing Revenue Market Share by Type (2021-2026) Table 29. Global Drug Repurposing Revenue Market Share by Type (2027-2032) Table 30. Global Drug Repurposing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Drug Repurposing Revenue Market Share by Application (2021-2026) Table 34. Global Drug Repurposing Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Drug Repurposing Product Portfolio Table 39. Novartis Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Drug Repurposing Product Portfolio Table 44. Pfizer Recent Development Table 45. AbbVie Company Information Table 46. AbbVie Business Overview Table 47. AbbVie Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. AbbVie Drug Repurposing Product Portfolio Table 49. AbbVie Recent Development Table 50. NuMedii Company Information Table 51. NuMedii Business Overview Table 52. NuMedii Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. NuMedii Drug Repurposing Product Portfolio Table 54. NuMedii Recent Development Table 55. Biovista Company Information Table 56. Biovista Business Overview Table 57. Biovista Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Biovista Drug Repurposing Product Portfolio Table 59. Biovista Recent Development Table 60. Astellas Pharma Company Information Table 61. Astellas Pharma Business Overview Table 62. Astellas Pharma Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Astellas Pharma Drug Repurposing Product Portfolio Table 64. Astellas Pharma Recent Development Table 65. Allergan Company Information Table 66. Allergan Business Overview Table 67. Allergan Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Allergan Drug Repurposing Product Portfolio Table 69. Allergan Recent Development Table 70. North America Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Drug Repurposing Market Size by Country (2021-2026) Table 76. North America Drug Repurposing Market Size by Country (2027-2032) Table 77. Europe Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Drug Repurposing Market Size by Country (2021-2026) Table 83. Europe Drug Repurposing Market Size by Country (2027-2032) Table 84. China Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 85. China Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 86. China Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 87. China Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Drug Repurposing Market Size by Country (2021-2026) Table 94. Asia Drug Repurposing Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Drug Repurposing Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Drug Repurposing Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Drug Repurposing Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Drug Repurposing Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Drug Repurposing Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Drug Repurposing Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Drug Repurposing Product Image Figure 2. Global Drug Repurposing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug Repurposing Market Share by Type: 2025 VS 2032 Figure 4. Neurodegenerative Diseases Image Figure 5. CNS Diseases Image Figure 6. Oncology Image Figure 7. Others Image Figure 8. Global Drug Repurposing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Drug Repurposing Market Share by Application: 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Ambulatory Surgical Centers Image Figure 12. Others Image Figure 13. Global Drug Repurposing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 15. Global Drug Repurposing Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Drug Repurposing Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Drug Repurposing Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Drug Repurposing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Repurposing Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Repurposing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Repurposing Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 25. North America Drug Repurposing Market Share by Type (2021-2032) Figure 26. North America Drug Repurposing Market Share by Application (2021-2032) Figure 27. North America Drug Repurposing Market Share by Country (2021-2032) Figure 28. United States Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 29. Canada Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 32. Europe Drug Repurposing Market Share by Type (2021-2032) Figure 33. Europe Drug Repurposing Market Share by Application (2021-2032) Figure 34. Europe Drug Repurposing Market Share by Country (2021-2032) Figure 35. Germany Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 36. France Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 38. Italy Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 39. Russia Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 41. China Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 42. China Drug Repurposing Market Share by Type (2021-2032) Figure 43. China Drug Repurposing Market Share by Application (2021-2032) Figure 44. Asia Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 45. Asia Drug Repurposing Market Share by Type (2021-2032) Figure 46. Asia Drug Repurposing Market Share by Application (2021-2032) Figure 47. Asia Drug Repurposing Market Share by Country (2021-2032) Figure 48. Japan Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 52. India Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 53. Australia Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Drug Repurposing Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Drug Repurposing Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Drug Repurposing Market Share by Country (2021-2032) Figure 58. Brazil Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 63. UAE Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 65. Chile Drug Repurposing Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Neurodegenerative Diseases
  • CNS Diseases
  • Oncology
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Novartis
  • Pfizer
  • AbbVie
  • NuMedii
  • Biovista
  • Astellas Pharma
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Neurodegenerative Diseases
  5. 1.2.3 CNS Diseases
  6. 1.2.4 Oncology
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Drug Repurposing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Ambulatory Surgical Centers
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Drug Repurposing Growth Trends by Region
  15. 1.5.1 Global Drug Repurposing Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Drug Repurposing Market Size by Region (2021-2026)
  17. 1.5.3 Drug Repurposing Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Drug Repurposing Market Dynamics
  1. 2.1 Drug Repurposing Industry Trends
  2. 2.2 Drug Repurposing Industry Drivers
  3. 2.3 Drug Repurposing Industry Opportunities and Challenges
  4. 2.4 Drug Repurposing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug Repurposing Revenue by Company (2021-2026)
  2. 3.2 Global Drug Repurposing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug Repurposing Key Company Head office and Area Served
  4. 3.4 Global Drug Repurposing Company, Product Type & Application
  5. 3.5 Global Drug Repurposing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug Repurposing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug Repurposing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug Repurposing Tier 1, Tier 2, and Tier 3
4 Drug Repurposing Market by Type
  1. 4.1 Global Drug Repurposing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug Repurposing Market Size by Type (2021-2032)
  3. 4.3 Global Drug Repurposing Market Size Share by Type (2021-2032)
5 Drug Repurposing Market by Application
  1. 5.1 Global Drug Repurposing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Repurposing Market Size by Application (2021-2032)
  3. 5.3 Global Drug Repurposing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Drug Repurposing Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Drug Repurposing Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 AbbVie Drug Repurposing Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 NuMedii
  20. 6.4.1 NuMedii Company Information
  21. 6.4.2 NuMedii Business Overview
  22. 6.4.3 NuMedii Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 NuMedii Drug Repurposing Product Portfolio
  24. 6.4.5 NuMedii Recent Developments
  25. 6.5 Biovista
  26. 6.5.1 Biovista Company Information
  27. 6.5.2 Biovista Business Overview
  28. 6.5.3 Biovista Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Biovista Drug Repurposing Product Portfolio
  30. 6.5.5 Biovista Recent Developments
  31. 6.6 Astellas Pharma
  32. 6.6.1 Astellas Pharma Company Information
  33. 6.6.2 Astellas Pharma Business Overview
  34. 6.6.3 Astellas Pharma Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Astellas Pharma Drug Repurposing Product Portfolio
  36. 6.6.5 Astellas Pharma Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Drug Repurposing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Allergan Drug Repurposing Product Portfolio
  42. 6.7.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Drug Repurposing Market Size (2021-2032)
  2. 7.2 North America Drug Repurposing Market Size by Type
  3. 7.2.1 North America Drug Repurposing Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug Repurposing Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug Repurposing Market Share by Type (2021-2032)
  6. 7.3 North America Drug Repurposing Market Size by Application
  7. 7.3.1 North America Drug Repurposing Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug Repurposing Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug Repurposing Market Share by Application (2021-2032)
  10. 7.4 North America Drug Repurposing Market Size by Country
  11. 7.4.1 North America Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug Repurposing Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug Repurposing Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug Repurposing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug Repurposing Market Size (2021-2032)
  2. 8.2 Europe Drug Repurposing Market Size by Type
  3. 8.2.1 Europe Drug Repurposing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug Repurposing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug Repurposing Market Share by Type (2021-2032)
  6. 8.3 Europe Drug Repurposing Market Size by Application
  7. 8.3.1 Europe Drug Repurposing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug Repurposing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug Repurposing Market Share by Application (2021-2032)
  10. 8.4 Europe Drug Repurposing Market Size by Country
  11. 8.4.1 Europe Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug Repurposing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug Repurposing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug Repurposing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug Repurposing Market Size (2021-2032)
  2. 9.2 China Drug Repurposing Market Size by Type
  3. 9.2.1 China Drug Repurposing Market Size by Type (2021-2026)
  4. 9.2.2 China Drug Repurposing Market Size by Type (2027-2032)
  5. 9.2.3 China Drug Repurposing Market Share by Type (2021-2032)
  6. 9.3 China Drug Repurposing Market Size by Application
  7. 9.3.1 China Drug Repurposing Market Size by Application (2021-2026)
  8. 9.3.2 China Drug Repurposing Market Size by Application (2027-2032)
  9. 9.3.3 China Drug Repurposing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug Repurposing Market Size (2021-2032)
  2. 10.2 Asia Drug Repurposing Market Size by Type
  3. 10.2.1 Asia Drug Repurposing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug Repurposing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug Repurposing Market Share by Type (2021-2032)
  6. 10.3 Asia Drug Repurposing Market Size by Application
  7. 10.3.1 Asia Drug Repurposing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug Repurposing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug Repurposing Market Share by Application (2021-2032)
  10. 10.4 Asia Drug Repurposing Market Size by Country
  11. 10.4.1 Asia Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug Repurposing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug Repurposing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug Repurposing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug Repurposing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug Repurposing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug Repurposing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug Repurposing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug Repurposing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug Repurposing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug Repurposing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug Repurposing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug Repurposing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug Repurposing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug Repurposing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug Repurposing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug Repurposing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug Repurposing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst